GlassScriptPhysician profile
Mouen Khashab
NPI 1679668909
$439,574.25
in general payments reported to CMS, 2019-2025
27 companies · $65K in 2025
The $65K reported for 2025 was more than what 98% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27K · 2020: $29K · 2021: $37K · 2022: $43K · 2023: $63K · 2024: $175K · 2025: $65K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $117K · Acquisitions: $80K · Consulting Fee: $50K · Education: $29K · Travel and Lodging: $15K · Food and Beverage: $6,429 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $5,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $116,891.51 |
| Acquisitions | $80,000.00 |
| Consulting Fee | $50,300.00 |
| Education | $29,066.50 |
| Travel and Lodging | $15,460.19 |
| Food and Beverage | $6,429.14 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $5,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $318,904.39 | 2019-2025 | General - Therapies, Acquire, Wallflex Duodenal |
| Olympus Corporation of The Americas | $30,568.36 | 2019-2025 | Olympus, Disposable Distal Attachment, Single Use Repositionable Clip |
| Pentax of America, INC. | $16,903.74 | 2019-2023 | C2 Cryoballoon |
| Medtronic, INC. | $14,853.90 | 2021-2025 | Barrx, Gi Genius, Nexpowder |
| Covidien LP | $14,287.79 | 2019-2020 | |
| Gi Supply, INC. | $13,100.52 | 2020-2021 | |
| Apollo Endosurgery US INC | $12,531.60 | 2019-2022 | |
| Micro-Tech Endoscopy USA, INC. | $6,856.69 | 2021-2025 | Eyemax, Dat Closure Device, Suretrac |
| Laborie Medical Technologies Corp. | $2,998.70 | 2022-2025 | |
| Exact Sciences Corporation | $2,474.43 | 2024 | Cologuard Collection Kit |
| Olympus America INC. | $1,390.08 | 2019-2025 | Visiglide, Single Use Repositionable Clip |
| Lumendi LLC | $800.00 | 2019 | |
| Conmed Corporation | $789.56 | 2021-2023 | Conmed Biliary |
| Ambu A/S | $750.00 | 2020 | |
| Abbvie INC. | $617.13 | 2019-2023 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fujifilm Healthcare Americas Corporation | $590.75 | 2023-2025 | Fujifilm |
| Creo Medical INC. | $312.00 | 2022-2024 | Speedboat Ultraslim (Sb1l) |
| Ambu INC. | $265.95 | 2020-2021 | |
| Erbe USA INC | $173.25 | 2024-2025 | Hk Flex |
| Endogastric Solutions, INC | $131.89 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $107.37 | 2021-2024 | Entyvio |
| 3-D Matrix, INC. | $52.68 | 2022-2024 | |
| Genzyme Corporation | $31.54 | 2024 | |
| Phathom Pharmaceuticals, INC. | $24.77 | 2024 | Voquezna |
| Gyrus Acmi, INC. | $22.82 | 2024 | |
| Merck Sharp & Dohme LLC | $20.30 | 2023 | Dificid |
| Mauna Kea Technologies, INC. | $14.04 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mouen Khashab listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.